Draft Guidance for Industry: Voluntary Sodium Reduction Goals: Target Mean and Upper Bound Concentrations for Sodium in Commercially Processed, Packaged, and Prepared Foods. June 2016. www.fda.gov/Food/GuidanceRegulation/GuidanceDocumentsRegulatoryInformation/ucm494732.htm.
Jackson S. L., King S. M., Zhao L., Cogswell M. E. Prevalence of Excess Sodium Intake in the United States-NHANES, 2009–2012. Morbidity and Mortality Weekly Report. 2016;64:1393–7.
American Heart Association Sodium Reduction Initiative Team. The Salty Six – Surprising Foods that Add the Most Sodium to our Diets. 2014. https://sodiumbreakup.heart.org/salty-six-surprising-foods-add-sodium-diets/.
Mente A., O’Donnell M., Rangarajan S., et al. Associations of Urinary Sodium Excretion with Cardiovascular Events in Individuals with and without Hypertension: A Pooled Analysis of Data from Four Studies. Lancet. 2016;388:465–75.
Has Salt Gotten an Unfair Shake? September 3, 2017. www.npr.org/sections/healthshots/2017/09/03/547827356/has-salt-gotten-an-unfair-shake-sodium-partisanssay-yes.
Jerusalem Talmud, Horeyot 3:5.
Berman LB. Harry Goldblatt: 1891–1977. Journal of the American Medical Association. 1977;238:1846.
Downey P. Profile of Sérgio Ferreira. Proceedings of the National Academy of Sciences of the United States of America. 2008;105:19035–7.
Patlak M. From Viper’s Venom to Drug Design: Treating Hypertension. FASEB Journal. 2004;18:421.
Johns E. J., Kopp U. C., DiBona G. F. Neural Control of Renal Function. Comprehensive Physiology. 2011;1:731–67.
Barnett H. J., Jackson M. V., Spaulding W. B. Thiocyanate Psychosis. Journal of the American Medical Association. 1951;147:1554–8.
Newcombe C. P., Shucksmith H. S., Suffern W. S. Sympathectomy for Hypertension; Follow-Up of 212 Patients. British Medical Journal. 1959;1:142–4.
Symplicity HTNI, Esler M. D., Krum H., et al. Renal Sympathetic Denervation in Patients with Treatment-Resistant Hypertension (The Symplicity HTN-2 Trial): A Randomised Controlled Trial. Lancet. 2010;376:1903–9.
Bhatt D. L., Kandzari D. E., O’Neill W.W., et al. A Controlled Trial of Renal Denervation for Resistant Hypertension. New England Journal of Medicine. 2014;370:1393–401.
Nes W. D. Biosynthesis of Cholesterol and Other Sterols. Chemical Reviews. 2011;111:6423–51.
Rifkind B. Drug Treatment of Hyperlipidemia. Boca Raton, FL: CRC Press; 1991.
Thoraco-Abdominal Aorta: Surgical and Anesthetic Management. Edited by Roberto Chiesa, Germano Melissano, Alberto Zangrillo. Milan: Springer Science & Business Media, 2011.
Stamler J. Lectures on Preventive Cardiology. New York: Grune & Stratton, Inc.; 1967.
Virchow R. Cellular Pathology as Based Upon Physiological and Pathological Histology. Philadelphia: JB Lippincott; 1863.
Benlian P. Genetics of Dyslipidemia. Milan: Springer Science & Business Media; 2001.
Konstantinov I. E., Mejevoi N., Anichkov N. M. Nikolai N. Anichkov and His Theory of Atherosclerosis. Texas Heart Institute Journal. 2006;33:417–23.
Vanitallie T. B. Ancel Keys: A Tribute. Nutrition & Metabolism (London). 2005;2:4.
Brozek J. Bibliographical Note on Behavioral Aspects: On the Margin of the 50th Anniversary of the Minnesota Starvation-Nutritional Rehabilitation Experiment. Perceptual Motor Skills. 1995;81:395–400.
Keys A. Human Atherosclerosis and the Diet. Circulation. 1952;5:115–8.
Keys A. Coronary heart disease in seven countries. 1970. Nutrition. 1997;13:250–2; discussion 49, 3.
Marmot M. G., Syme S. L. Acculturation and Coronary Heart Disease in Japanese-Americans. American Journal of Epidemiology. 1976;104:225–47.
Dayton S., Pearce M. L., Goldman H., et al. Controlled Trial of a Diet High in Unsaturated Fat for Prevention of Atherosclerotic Complications. Lancet. 1968;2:1060–2.
Miettinen M., Turpeinen O., Karvonen M. J., Elosuo R., Paavilainen E. Effect of Cholesterol-Lowering Diet on Mortality from Coronary Heart-Disease and Other Causes. A Twelve-Year Clinical Trial in Men and Women. Lancet. 1972;2:835–8.
Demaret K., Weinraub, J. Dr. George Mann Says Low Cholesterol Diets Are Useless, but the “Heart Mafia” Disagrees. People. January 22, 1979.
Mann G. V. Diet-Heart: End of an Era. New England Journal of Medicine. 1977;297:644–50.
Dietary Fat and Its Relation to Heart Attacks and Strokes. Report by the Central Committee for Medical and Community Program of the American Heart Association. Journal of the American Medical Association. 1961;175:389–91.
McMichael J. Fats and Atheroma: an Inquest. British Medical Journal. 1979;1:173–5.
Steinberg D. The Pathogenesis of Atherosclerosis. An Interpretive History of the Cholesterol Controversy, Part IV: The 1984 Coronary Primary Prevention Trial Ends It – Almost. Journal of Lipid Research. 2006;47:1–14.
The Lipid Research Clinics Coronary Primary Prevention Trial Results. II. The Relationship of Reduction in Incidence of Coronary Heart Disease to Cholesterol Lowering. Journal of the American Medical Association. 1984;251:365–74.
Mann G. Coronary Heart Disease–“Doing the Wrong Thing.” Nutrition Today. 1985:12–4.
Endo A. A Historical Perspective on the Discovery of Statins. Proceedings of the Japan Academy Series B – Physical and Biological Sciences. 2010;86:484–93.
Там же.
Stossel T. P. The Discovery of Statins. Cell. 2008;134:903–5.
Pedersen T. R., Kjekshus J., Berg K., et al. Randomized Trial of Cholesterol-Lowering in 4444 Patients with Coronary Heart Disease: the Scandinavian Simvastatin Survival Study (4S). Lancet. 1994;344:1383–9.
Tang J. L., Armitage J. M., Lancaster T., Silagy C. A., Fowler G. H., Neil HAW. Systematic Review of Dietary Intervention Trials to Lower Blood Total Cholesterol in Free-Living Subjects. British Medical Journal. 1998;316:1213–9.
Bhattarai N., Prevost A. T., Wright A. J., Charlton J., Rudisill C., Gulliford MC. Effectiveness of Interventions to Promote Healthy Diet in Primary Care: Systematic Review and Meta-Analysis of Randomised Controlled Trials. BMC Public Health. 2013;13.
Collins R., Reith C., Emberson J, et al. Interpretation of the Evidence for the Efficacy and Safety of Statin Therapy. Lancet. 2016;388:2532–61.
Salami JA, Warraich H., Valero-Elizondo J, et al. National Trends in Statin Use and Expenditures in the US Adult Population From 2002 to 2013 Insights from the Medical Expenditure Panel Survey. JAMA Cardiology. 2017;2:56–65.
Читать дальше
Конец ознакомительного отрывка
Купить книгу